Dr. Jonathan Schoeff

speaker

2,131 appearances 2 recordings 1 series first heard Jul 2026 last heard 28 Jul

Dr. Jonathan Schoeff’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 2 in all, peaking in Jul 2026 with 2.

Appearances

newest first · ▶ plays the moment

Habits and Hustle · Episode 575: Dr. Jonathan Schoeff: Peptides and the Marketing Behind Modern Longevity - Part 2 · 28 Jul 2026 podcast

Those are peptides, but guess what the common threat is?

Tessamorelin exists as a pharmaceutical agent.

It went through the entire FDA clearance process.

There tends to be a connection, and so this is where Tessamorelin's a workhorse.

MOTC

That goes back to your original question.

There is actually no evidence, and I've looked at MOTC strategically at high doses, because for me, to say there's some positive benefit, it has to follow a logical train of thought.

And if you're talking about mitochondrial-optimizing peptide, it's MOTC,

you would expect one of two, if not two things to happen.

One, fuel utilization increases.

You can test that.

It's called resting metabolic rate.

So I looked at myself, I did the study on myself.

I did every week, I did an indirect calorimetry.

So a breath breathing test, mask on my face, checked my RMR, didn't change, did not change.

So could there be something happening on a small scale?

Yeah, but if it's not having a meaningful impact on the human, why are you taking it?

Yeah, huge, massive.

Potency, efficacy.

Okay.

Showing 901–920 of 2,131 · page 46 of 107